<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    GENFIT S.A.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $768,800,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Jean-François Mouney
    • FOUNDED
      1999
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Biofrontera AG

    Biofrontera AG

    We have specialized in dermatology, as your skin's health is our concern. We aim t...

    We have specialized in dermatology, as your ski...

    Filing Type:    PU
    Bio-Techne Corp

    Bio-Techne Corp

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of h...

    Bio-Techne Corporation (NASDAQ: TECH) is a lead...

    Filing Type:    PU
    EVELO, Inc.

    EVELO, Inc.

    Evelo develops and sells electric bicycles using a direct-to-consumer distribution...

    Evelo develops and sells electric bicycles usin...

    Amount Raised:    $729,723.00
    Fundraising Status:    VT
    Filing Type:    CF
    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals is driven to deliver novel, transformational medicines with ...

    Arena Pharmaceuticals is driven to deliver nove...

    Filing Type:    PU
    Novartis AG

    Novartis AG

    Novartis is reimagining medicine to improve and extend people’s lives. As a leadin...

    Novartis is reimagining medicine to improve and...

    Filing Type:    PU
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.